2009-11-10 16:34:04 -

Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced the expansion of their management team today with the addition of Zi-Ping Fang, PhD, as Chief Technology Officer. This follows their recent $1.8 million A round fundraising.

Dr. Fang holds over 25 years of neurostimulation technology development and clinical research experience, including post-doctoral

training in Neuroscience from Case Western Reserve University’s (CWRU) School of Medicine, and a PhD in Biomedical Engineering, also from CWRU. He has held several executive level positions in the industry.

Dr. Fang will lead Neuros Medical’s technology and clinical development efforts for the company’s neurostimulation technology focusing on the chronic pain market.

“I am very pleased to join the Neuros team,” said Dr. Fang. “I have been impressed with their progress over the past year and am enthusiastic for our nerve block applications in the chronic pain market.”


Neuros Medical also announced the forming of their Clinical Advisory Board, lead by Dr. Amol Soin. Dr. Soin, a Cleveland Clinic Hospital trained Interventional Pain Physician, is the Operating Founder of The Ohio Pain Clinic, a network of chronic pain clinics in Southwest Ohio.

“I believe that the Neuros Medical nerve block technology has the potential to make a major impact in the treatment of chronic pain,” stated Dr. Soin. “As a practicing physician who sees the frustration that patients have to experience due to a lack of effective pain treatment available to them, the Neuros Medical technology has the potential to positively alter the chronic pain treatment landscape.”


“We are fortunate to have the additions of leaders such as Drs. Fang and Soin on our team,” indicated Jon J. Snyder, President and CEO of Neuros Medical. “They will be instrumental in moving our technology into the marketplace as a treatment option for chronic pain.”


About Neuros Medical, Inc.

Neuros Medical, a Cleveland, Ohio based neurostimulation company, is focused on developing proprietary neurostimulation therapies for unmet needs to patients worldwide. The company’s patented platform technology, Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post surgical pain, and chronic migraine.

Neuros Medical, Inc.Jon J. Snyder, President and CEO, 440-951-BLOK
(2565)440-487-7515 jsnyder@neurosmedical.com : mailto:jsnyder@neurosmedical.com